Bill Malone wrote a great article for Clinical laboratory News (American Assoc for Clinical Chemistry) that goes straight to the heart of the folklore and myth surrounding the use of automation in laboratories. Check out “Blood, Sweat, and Robots.”
Working together, companies offer enhanced abilities to monitor immunotherapy response in vaccine and drug studies.
It is of concern of all in pharma and biotech research fields that the number of vaccines and drugs that get to the market is very low compared to the number that enter phase I clinical trial testing. For this to change, among other improvements, new surrogate markers must be identified early on for the purpose of patient stratification, immune monitoring and/or therapeutic or prophylactic efficacy assessment.
IMMUNOSITE TECHNOLOGIES, LLC
P.O. Box 165937, Miami, FL 33116, USA
4981 SW 74 Court, Miami, FL 33155, USA
Telephone: (954) 462-6800
@2009 - 2018 ImmunoSite Technologies, LLC. All rights reserved.
